Form 4: Pacira BioSciences COO Daryl Gaugler Reports Acquisition of Common Stock

Pacira BioSciences' Chief Operating Officer, Daryl Gaugler, acquired shares of common stock through the company's employee stock purchase plan.

Summary

• On June 28, 2024, Daryl Gaugler, the Chief Operating Officer of Pacira BioSciences, Inc., acquired 160.368 shares of common stock.
• The shares were acquired through the issuer's employee stock purchase plan at a price of $24.319 per share.
• Following the transaction, Gaugler directly owns 116,199.952 shares of Pacira BioSciences common stock.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing, reflecting a standard transaction. It doesn't inherently convey positive or negative sentiment.

Positives

• The acquisition of shares through the employee stock purchase plan demonstrates the executive's investment in the company's future.

Future Outlook

There are no forward-looking statements in this document.

Industry Context

This Form 4 filing is a routine disclosure related to insider trading activity, which is common among publicly traded companies. It provides transparency into the transactions of company executives and their ownership stake in the company.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it represents a routine acquisition of shares by a company executive.

Key Dates